PDL BioPharma Inc. (PDLI) tumbled -6.1% or -0.22 to $3.46. It is approximately 1.55 million shares traded, which is 101.25% compare to the average total volume 1.53 million. The market cap of PDLI is $443.90 million. The year to date change is 20.71%. The 52 week price range is from $2.25 to $3.89. Price of PDLI have changed -4.16% during last week. It have changed 3.94% over last month, 16.77% over last 3 months, 44.71% over last 6 months and 23.00% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PDLI is 3.59. It is 3.76% above current price. The 200-day Moving Averages for PDLI is 2.90. It is -16.18% below current price. The 52-week High is 3.89. It is 12.43% from the current price. The 52-week Low is 2.25. It is -34.97% from current price.
There are some statistics of PDLI. It is has market cap $443.90 million. The share outstanding is 128.11 million. The average volume is 1.53 million. The percent of top 15 Institution holding is 132.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PDLI is -8.95%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PDLI is -6.39%.